Hematology/Oncology

Top Story

Early radioactive iodine initiation may improve treatment response after thyroidectomy

January 18, 2018
Meeting News

Ramucirumab reduces risk for progression in certain gastric cancers

January 18, 2018
The addition of ramucirumab to first-line chemotherapy conferred a 25% reduction in risk for disease progression or death among treatment-naive patients with metastatic…
In the Journals Plus

Hyperthermic intraperitoneal chemotherapy prolongs ovarian cancer survival

January 17, 2018
The addition of hyperthermic intraperitoneal chemotherapy to interval cytoreductive surgery prolonged RFS and OS without increasing toxicity among patients with stage…
In the Journals Plus

Elimination of cost-sharing under ACA increases access to mammography

January 17, 2018
The rate of mammography increased six percentage points among older women for whom it is recommended following the elimination of screening cost-sharing under the…
FDA News

FDA grants fast track designation to RM-1929 for HNSCC

January 17, 2018
The FDA granted breakthrough therapy designation to RM-1929 for the treatment of patients with locoregional recurrent head and neck squamous cell carcinoma who have…
More Headlines »
CME

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immunotherapies into management strategies for the treatment of numerous hard-to-treat malignancies…
More »
Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME

Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

In 2016, the first immune checkpoint inhibitor was approved by the US Food and Drug Administration (FDA) for the…
More »
Current Issues
View the Current Issue
HemOnc Today